Abstract:Chickenpox infections are generally mild but due to their very high incidence among healthy children they give rise to considerable morbidity and occasional mortality. With the development of a varicella vaccine in the early 1970s and its progressive licensing in many countries, interest in the efficiency of varicella immunisation programmes grew. The objective of this review was to discuss the methodological aspects and results of published economic evaluations of varicella vaccination. From this, we attempted to make recommendations. A computerised search was carried out; 17 full economic evaluations of varicella vaccination were retrieved. The review identified the methodological divergences and similarities between the articles in four areas: study design, epidemiological data, economic data and model characteristics. We assessed to what extent the applied methods conform to general guidelines for the economic evaluation of healthcare interventions and compared the studies' results. The desirability of a universal vaccination programme depends on whose perspective is taken. Despite variability in data and model assumptions, the studies suggest that universal vaccination of infants is attractive to society because large savings occur from averted unproductive days for parents. For the healthcare payer, universal vaccination of infants does not generate savings. Vaccination of susceptible adolescents has been proposed by some authors as a viable alternative; the attractiveness of this is highly dependent on the negative predictive value of anamnestic screening. Targeted vaccination of healthcare workers and immunocompromised individuals appears relatively cost effective. Findings for other target groups are either contradictory or provide insufficient evidence for any unequivocal recommendations to be made. High sensitivity to vaccine price was reported in most studies. This review highlights that some aspects of these studies need to be further improved before final recommendations can be made. First, more transparency, completeness and compliance to general methodological guidelines are required. Second, because of the increasing severity of varicella with age, it is preferable and in some cases essential to use dynamic models for the assessment of universal vaccination strategies. Third, most studies focused on the strategy of vaccinating children only while their results depended heavily on disputable assumptions (regarding vaccine effectiveness and impact on herpes zoster). Since violation of these assumptions could have important adverse public health effects, we suggest pre-adolescent vaccination as a more secure alternative. This option deserves more attention in future analyses.

Economic evaluation of vaccination programs: the impact of herd-immunity

Incorporating Game Theory Into Voluntary Vaccination

The broader benefits of vaccines: methodologies for inclusion in economic evaluation

Dynamic transmission models and economic evaluations of pneumococcal conjugate vaccines: a quality appraisal and limitations

Using private demand studies to calculate socially optimal vaccine subsidies in developing countries

Simple economics of vaccination: public policies and incentives

Economic Evaluation of Vaccination Programs: A Guide for Selecting Modeling Approaches

Evolutionary dynamics of voluntary vaccination for imperfect multi-efficacy vaccines

Estimating the Fiscal Consequences of National Immunization Programs Using a "Government Perspective" Public Economic Framework

Pharmacoeconomics of immunisation: a review

Influence of waning immunity on vaccination decision-making: A multi-strain epidemic model with an evolutionary approach analyzing cost and efficacy

Quantifying indirect and direct vaccination effects arising in the SIR model

Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community

The Effect of Vaccination on the Competitive Advantage of Two Strains of an Infectious Disease

Do current economic evaluations fully capture vaccine value: a review of evidence from India

Economic evaluations of varicella vaccination programmes: a review of the literature

Modelling the impact of immunization on the epidemiology of varicella zoster virus

Modelling a cost-effective vaccination strategy for the prevention of varicella and herpes zoster infection: A systematic review

Inclusion of Additional Unintended Consequences in Economic Evaluation: A Systematic Review of Immunization and Tuberculosis Cost-Effectiveness Analyses

Herd immunity, vaccination and moral obligation

Inviting free-riders or appealing to prosocial behavior? Game-theoretical reflections on communicating herd immunity in vaccine advocacy.